Search results
Latest Market News Today Live Updates July 5, 2024: Gold Prices Today: Yellow metal hits one-month...
Livemint· 2 days agoLatest Market News Today Live Updates: Follow Mint's market blog for real-time updates on your...
Emcure Pharma IPO receives strong response, subscribed 67.86 times on third bidding day; Issue...
Livemint· 2 days agoAccording to data collected from the Bombay Stock Exchange (BSE) website, the Emcure Pharmaceuticals...
Market stalls at record highs: Nervous investors book profits, await US jobs data
Business Standard India· 2 days agoThe headline equity indices ended almost flat on Friday. Nervous investors cashed in profits at...
Ganesh Green Bharat IPO sails through first day of bidding; retail, NII portion sees huge demand....
Livemint· 2 days agoGanesh Green Bharat IPO subscriptions started on July 5 and will end on July 9, with a lot size of...
MBL Infrastructure Ltd Stock Price: MBL Infrast Share Price Today | India Infoline
India Infoline· 3 days agoMBL Infrast Share Price: Get the live NSE/BSE stock price of MBL Infrastructure Ltd with performance, market cap, financial report, and company profile at India Infoline.
Stock Market Today | Bombay Stock Exchange Updates | Global Stock Market News
CNBC Awaaz· 3 days agoGet stock market today live updates, bombay stock exchange, global and indian stock market news on a single platform anytime anywhere with ease .
Emcure Pharmaceuticals IPO day 2: GMP, subscription status, review to allotment date. Apply or not?...
Livemint· 4 days agoEmcure Pharmaceuticals IPO GMP: Shares of the company are available at a premium of ₹333 in the grey...
Emcure Pharmaceuticals IPO: 10 key risks investors should consider before subscribing to the...
Livemint· 5 days agoThe IPO consists of a new issue of equity shares valued at ₹800 crore and an offer of sale (OFS) by...
Why celebrities are tearing down historic homes, Ikea is coming to Fifth Avenue, and more
BUSINESS OF HOME· 5 days agoThis week in design, Kohler collaborates with Daniel Arsham, a wave of aesthetically pleasing AC...
These two stocks can act as Rahul Dravid of your portfolio: Gautam Shah
The Economic Times· 6 days agoGautam Shah: Well, pharma has been a brilliant story for the last one year. Now it saw a breakout...